These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35125267)

  • 1. Treatment outcomes of proton beam therapy combined with retrograde intra-arterial infusion chemotherapy for locally advanced oral cancer in the elderly.
    Kitabatake T; Takayama K; Tominaga T; Hayashi Y; Seto I; Yamaguchi H; Suzuki M; Wada H; Kikuchi Y; Murakami M; Mitsudo K
    Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1264-1272. PubMed ID: 35125267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
    Hayashi Y; Nakamura T; Mitsudo K; Yamaguchi H; Ono T; Azami Y; Takayama K; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Fuwa N; Tohnai I
    Head Neck; 2016 Aug; 38(8):1145-51. PubMed ID: 27018982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
    Takayama K; Nakamura T; Takada A; Makita C; Suzuki M; Azami Y; Kato T; Hayashi Y; Ono T; Toyomasu Y; Hareyama M; Kikuchi Y; Daimon T; Mitsudo K; Tohnai I; Fuwa N
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):659-67. PubMed ID: 26521257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer.
    Hayashi Y; Nakamura T; Mitsudo K; Kimura K; Yamaguchi H; Ono T; Azami Y; Takayama K; Hirose K; Yabuuchi T; Suzuki M; Hatayama Y; Kikuchi Y; Wada H; Fuwa N; Hareyama M; Tohnai I
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e394-e401. PubMed ID: 27220486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
    Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
    Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old.
    Hayashi Y; Mitsudo K; Sakuma K; Iida M; Iwai T; Nakashima H; Okamoto Y; Koizumi T; Oguri S; Hirota M; Kioi M; Koike I; Hata M; Tohnai I
    Radiat Oncol; 2017 Jul; 12(1):112. PubMed ID: 28673362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
    Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
    Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Beam Therapy in Combination with Intra-Arterial Infusion Chemotherapy for T4 Squamous Cell Carcinoma of the Maxillary Gingiva.
    Endo H; Takayama K; Mitsudo K; Nakamura T; Seto I; Yamaguchi H; Ono T; Suzuki M; Azami Y; Wada H; Murakami M; Tohnai I
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30223580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial.
    Li Y; Li LJ; Wang LJ; Zhang Z; Gao N; Liang CY; Huang YD; Han B
    BMC Med; 2014 Jan; 12():16. PubMed ID: 24479409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasis.
    Minamiyama S; Mitsudo K; Hayashi Y; Iida M; Iwai T; Nakashima H; Oguri S; Ozawa T; Koizumi T; Hirota M; Kioi M; Tohnai I
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jul; 124(1):16-23. PubMed ID: 28434836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial plus i.v. chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa.
    Wang HM; Ng SH; Wang CH; Liaw CT; Chen JS; Yang TS; Chen IH
    Anticancer Drugs; 2001 Apr; 12(4):331-7. PubMed ID: 11335789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Safety of Super-Selective Intra-Arterial Infusion Chemotherapy for Induction with Docetaxel, Cisplatin, and 5-Fluorouracil for Oral Cancer].
    Hiraiwa T; Koike M; Okada H; Senda N; Suzuki K
    Gan To Kagaku Ryoho; 2015 Nov; 42(11):1385-9. PubMed ID: 26602396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 cases.
    Mitsudo K; Hayashi Y; Minamiyama S; Ohashi N; Iida M; Iwai T; Oguri S; Koizumi T; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
    Oral Oncol; 2018 Apr; 79():71-77. PubMed ID: 29598953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
    Mitsudo K; Koizumi T; Iida M; Iwai T; Oguri S; Yamamoto N; Itoh Y; Kioi M; Hirota M; Tohnai I
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e639-45. PubMed ID: 22543212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
    Yamshita Y; Shikimori M; Goto M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1267-71. PubMed ID: 16184922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
    Kobayashi W; Teh BG; Sakaki H; Sato H; Kimura H; Kakehata S; Nagahata M
    Oral Oncol; 2010 Dec; 46(12):860-3. PubMed ID: 21050802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma.
    Mukai Y; Hata M; Mitsudo K; Koike I; Koizumi T; Oguri S; Kioi M; Omura M; Tohnai I; Inoue T
    Strahlenther Onkol; 2014 Feb; 190(2):181-5. PubMed ID: 24264464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
    Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y;
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study.
    Nagai N; Oshita T; Murakami J; Shigemasa K; Hirokawa Y; Ohama K
    Oncol Rep; 2001; 8(1):119-25. PubMed ID: 11115582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.